Condition: Idiopathic Intracranial Hypertension (IIH) · Sponsor: University of Valencia
1. To establish the correlation between the evolution of the body mass index in benign intracranial hypertension and the response to treatments. 2. To establish the BMI at which this disease occurs. 3. To establish how much the BMI must be reduced to cure this disease. 4. To assess the evolution and response to treatments of sick people who DO NOT reduce or even continue to increase their BMI despite treatment with Acetazolamide or a possible CSF diversion
This description comes directly from the study's public registry record.
Vicente Vanaclocha, Professor · + 34 963 13 18 00 · vivava@uv.es
Teresa Moratal, Secretary · + 34 963 13 18 00 · moratal_ter@fihguv.es
Always discuss trial participation with your own doctor first.
| Consorcio Hospital General Universitario de Valencia | Valencia, Valencia, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06913712